Ginkgo Bioworks Announces Ginkgo Datapoints Agreement With Eli Lilly's TuneLab To Provide Small Molecule And Antibody Developability Testing
Share
Why It Matters
Ginkgo Bioworks will help Eli Lilly test new medicines faster. This shows Ginkgo is useful to big companies building drugs.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.